Praxis Precision Medicines, Inc.PRAXNASDAQ
Loading
Year-over-year research & development expense growth
5Y CAGR
-8.2%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 17.80% |
| Q3 2025 | 4.43% |
| Q2 2025 | 3.62% |
| Q1 2025 | 8.03% |
| Q4 2024 | 34.40% |
| Q3 2024 | 53.64% |
| Q2 2024 | 1.02% |
| Q1 2024 | 46.75% |
| Q4 2023 | 6.54% |
| Q3 2023 | -32.61% |
| Q2 2023 | 0.43% |
| Q1 2023 | -9.97% |
| Q4 2022 | -6.93% |
| Q3 2022 | -30.22% |
| Q2 2022 | -17.15% |
| Q1 2022 | 21.01% |
| Q4 2021 | 31.30% |
| Q3 2021 | 29.06% |
| Q2 2021 | 43.22% |
| Q1 2021 | 10.18% |
| Q4 2020 | 27.26% |
| Q3 2020 | 41.28% |
| Q2 2020 | 31.77% |
| Q1 2020 | 20.51% |
| Q4 2019 | -39.02% |
| Q3 2019 | 28.80% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |